TY - JOUR
T1 - Age-standardized incidence and mortality rates of oral and pharyngeal cancer in Puerto Rico and among Non-Hispanics Whites, Non-Hispanic Blacks, and Hispanics in the USA
AU - Suárez, Erick
AU - Calo, William A.
AU - Hernández, Eduardo Y.
AU - Diaz, Elba C.
AU - Figueroa, Nayda R.
AU - Ortiz, Ana P.
N1 - Funding Information:
This project was supported by NIH Grant #U54CA96297 from the Puerto Rico Cancer Center/M.D. Anderson Cancer Center Partnership and RCMI Grant #G12RR03051 from the University of Puerto Rico. The Puerto Rico Central Cancer Registry was supported, in part, by CDC-NPCR Grant #U58DP000782-01. We acknowledge the collaboration of the Puerto Rico Central Cancer Registry with data facilitation. Also, we thank Laura Bretaña for her help in editing the document (NIH NCRR RCMI Grant #G12RR03051). We acknowledge the contributions of doctors Richard B. Hayes from the Division of Cancer Epidemiology and Genetics, National Cancer Institute and Dominique Michaud from the Imperial College of London in the review of this manuscript.
PY - 2009/4/28
Y1 - 2009/4/28
N2 - Background: In the American region, Puerto Rico (PR) has the highest incidence of oral and pharyngeal cancer (OPC), but racial/ethnic differences have never been assessed and compared with other groups in the United States of America (USA). We compared the age-adjusted incidence and mortality rates of OPC between PR and among USA Hispanics (USH), Non-Hispanic Whites (NHW), and Non-Hispanic Blacks (NHB) to assess the burden of this cancer in PR. Methods: Analysis of the age-standardized rates (per 100,000) was performed using the direct method with the world standard population (ASR(World)) from 1998-2002. Annual percent change (APC) and Relative Risks (RR) were calculated using the Poisson regression model. Results: The incidence ASR(World) for men in PR was constant (APC ≈ 0.0%), in contrast, a decrease was observed among NHW, NHB, and USH men, although only USH showed statistical significance (APC = -4.9%, p < 0.05). In women, the highest increase in incidence (APC = 5.3%) and the lowest decrease in mortality (APC = -1.4%) was observed in PR. The ratio of the ASR(World) showed that in all racial/ethnic groups, men had approximately 2-4 fold increased incidence and mortality risk of OPC than women (p < 0.05). Men in PR had a higher mortality risk (p < 0.05) of OPC as compared to USH, NHW, and NHB; but among women, PR showed a significant excess of mortality only as compared to USH (est. SRR = 1.82, 95% CI = 1.41, 2.33). Conclusion: The overall higher incidence of OPC in men in PR as compared to USH, NHB, and NHW could be explained by the effect of gene-environment interactions. Meanwhile, the higher mortality from OPC in PR suggests limitations in the health-care access within this population. Further research is warranted to elucidate these findings.
AB - Background: In the American region, Puerto Rico (PR) has the highest incidence of oral and pharyngeal cancer (OPC), but racial/ethnic differences have never been assessed and compared with other groups in the United States of America (USA). We compared the age-adjusted incidence and mortality rates of OPC between PR and among USA Hispanics (USH), Non-Hispanic Whites (NHW), and Non-Hispanic Blacks (NHB) to assess the burden of this cancer in PR. Methods: Analysis of the age-standardized rates (per 100,000) was performed using the direct method with the world standard population (ASR(World)) from 1998-2002. Annual percent change (APC) and Relative Risks (RR) were calculated using the Poisson regression model. Results: The incidence ASR(World) for men in PR was constant (APC ≈ 0.0%), in contrast, a decrease was observed among NHW, NHB, and USH men, although only USH showed statistical significance (APC = -4.9%, p < 0.05). In women, the highest increase in incidence (APC = 5.3%) and the lowest decrease in mortality (APC = -1.4%) was observed in PR. The ratio of the ASR(World) showed that in all racial/ethnic groups, men had approximately 2-4 fold increased incidence and mortality risk of OPC than women (p < 0.05). Men in PR had a higher mortality risk (p < 0.05) of OPC as compared to USH, NHW, and NHB; but among women, PR showed a significant excess of mortality only as compared to USH (est. SRR = 1.82, 95% CI = 1.41, 2.33). Conclusion: The overall higher incidence of OPC in men in PR as compared to USH, NHB, and NHW could be explained by the effect of gene-environment interactions. Meanwhile, the higher mortality from OPC in PR suggests limitations in the health-care access within this population. Further research is warranted to elucidate these findings.
UR - http://www.scopus.com/inward/record.url?scp=66149173553&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=66149173553&partnerID=8YFLogxK
U2 - 10.1186/1471-2407-9-129
DO - 10.1186/1471-2407-9-129
M3 - Article
C2 - 19400958
AN - SCOPUS:66149173553
SN - 1471-2407
VL - 9
JO - BMC Cancer
JF - BMC Cancer
M1 - 129
ER -